BARBARA MICHAEL: Open Payments
NPI 1962616789 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 41 payments from 17 companies in 2025. Trend: 2023 $372 · 2024 $835 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $180 |
| Lilly USA, LLC | 6 | $97 |
| PFIZER INC. | 4 | $67 |
| Organogenesis Inc. | 1 | $55 |
| Abbott Laboratories | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| ABIOMED | 1 | $47 |
| C2N Diagnostics, LLC | 1 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Dynavax Technologies Corporation | 2 | $33 |
Products named: Ozempic, MOUNJARO, Wegovy, APLIGRAF, JARDIANCE, FREESTYLE LIBRE 3, REXULTI, PRECIVITYAD2.
Industry payments across NC — which companies pay providers there.
